Corrections: An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling (Cancer Cell (2016) 30(3) (501–503) (S1535610816302847) (10.1016/j.ccell.2016.06.024))

Zoi Karoulia, Yang Wu, Tamer A. Ahmed, Qisheng Xin, Julien Bollard, Clemens Krepler, Xuewei Wu, Chao Zhang, Gideon Bollag, Meenhard Herlyn, James A. Fagin, Amaia Lujambio, Evripidis Gavathiotis, Poulikos I. Poulikakos

Research output: Contribution to journalComment/debate

11 Scopus citations

Abstract

(Cancer Cell 30, 485–498; September 12, 2016) During figure preparation for the version of this paper originally published online on August 11, 2016, the left column of western blots in Figures 1A and 1D was inadvertently labeled “pERK” instead of the correct “pMEK.” Figure 1 has now been corrected online and is shown below. The authors apologize for the error and any confusion it might have caused.

Original languageEnglish (US)
Pages (from-to)501-503
Number of pages3
JournalCancer Cell
Volume30
Issue number3
DOIs
StatePublished - Sep 12 2016

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'Corrections: An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling (Cancer Cell (2016) 30(3) (501–503) (S1535610816302847) (10.1016/j.ccell.2016.06.024))'. Together they form a unique fingerprint.

  • Cite this

    Karoulia, Z., Wu, Y., Ahmed, T. A., Xin, Q., Bollard, J., Krepler, C., Wu, X., Zhang, C., Bollag, G., Herlyn, M., Fagin, J. A., Lujambio, A., Gavathiotis, E., & Poulikakos, P. I. (2016). Corrections: An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling (Cancer Cell (2016) 30(3) (501–503) (S1535610816302847) (10.1016/j.ccell.2016.06.024)). Cancer Cell, 30(3), 501-503. https://doi.org/10.1016/j.ccell.2016.08.008